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ABSTRACT
Objective: The objective of this study is to analyze the correlation between locus polymorphisms of genetics variants of rs3753841 (COL11A1) and 
ocular biometry, including anterior chamber depth (ACD), axial length (AL), and lens thickness (LT) in acute and chronic primary angle-closure 
glaucoma (PACG) patients.
Methods: A total of 50 patients consisting of 25 acute PACG and 25 chronic PACG patients were included in this study. Ocular biometric parameters 
including anterior ACD, AL, and LT measurement were performed in all subjects using A-scan biometry. DNA isolation from blood samples was 
performed using PCR sequencing for genotyping locus polymorphisms of rs3753841 (COL11A1).
Results: Mean ACD was shallower (2.40±0.40 mm), mean AL was shorter (21.86±1.31 mm), and mean LT was thicker (5.01±0.49 mm) in acute PACG 
compared to chronic PACG group, yet with no significant difference (p>0.05). We found a statistically significant difference of rs3753841 (COL11A1) 
polymorphism, with heterozygous mutant was mostly found in chronic PACG and homozygous mutant was mostly found in acute PACG patients 
(p<0.05). Significant correlations were also found between the locus polymorphism and ocular biometry (ACD and AL) in chronic PACG (p<0.05).
Conclusion: We confirmed the polymorphisms of rs3753841 (COL11A1) in both groups and its significant correlation with ocular biometry 
(ACD and AL) in chronic PACG.
Keywords: Primary angle-closure glaucoma, Anterior chamber depth, Axial length, Lens thickness, rs3753841 (COL11A1).
INTRODUCTION
Primary angle-closure glaucoma (PACG) is one of the leading causes 
of irreversible blindness worldwide. Primary open-angle glaucoma 
(POAG) was known to be more frequent than PACG, but it is estimated 
that PACG can cause blindness five times more than POAG [1,2]. Early 
detection of PACG by effective screening and appropriate prophylaxis 
may help prevent blindness [3].
Angle-closure has been proved to be related with ocular biometric 
parameters, such as shallow anterior chamber depth (ACD), short 
axial length (AL), and thick crystalline lens. Shallow ACD (<2.5 mm) 
predisposes to PACG. Various studies have found a correlation between 
ACD, AL, and lens thickness (LT) in PACG, but to our knowledge, there 
have been no studies comparing ocular biometry with subtypes of 
acute and chronic PACG.
Genome wide association study found genetic variants of rs3753841 
(COL11A1) which is susceptible to PACG [4]. It was also supported 
by several other studies in different countries and ethnicities [5,6]. 
Polymorphism of COL11A1 gene was linked to unprogressive axial 
myopia, possibly caused by a distorted fibrilar collagen matrix in the 
sclera. Meanwhile, eyes with PACG are usually hypermetropic with 
shorter AL and “crowded” anterior segment. Therefore, the variant of 
the COL11A1 gene that leads to PACG might have a different expression 
compared to the opposite effect observed in eyes with myopia [4,7]. In 
this study, we aimed to assess polymorphisms of rs3753841 (COL11A1) 
and its correlation with ocular biometry (ACD, AL, and LT) in acute and 
chronic PACG.
METHODS
This study was an observational study with a cross-sectional 
comparative study design, taking place in Dr. M. Djamil General 
Hospital Padang, West Sumatra-Indonesia, from March to December 
2019. We obtained approval from the ethics committee with registered 
number 346/KEP/FK/2019. The subjects of this study were acute 
and chronic PACG patients who met the inclusion criteria. All patients 
were examined and diagnosed by an experienced glaucoma consultant. 
Patients with media opacities, history of ocular trauma, history of 
previous trabeculectomy, history of lens extraction, and other ocular 
surgeries were excluded from this study.
We enrolled 50 patients in this study which consisted of 25 acute PACG 
patients and 25 chronic PACG patients. All subjects underwent complete 
ophthalmology examination of the anterior and posterior segment. 
Contact (non-immersion) ultrasonic biometry was performed (Nidek 
Co. Ltd, Gamagori, Japan) to measure AL, ACD, and LT in all subjects. We 
included one eye which met the inclusion criteria and if both eyes had 
symmetrical condition, the right eye was chosen.
The ACD measurement was classified into three categories; shallow 
(<2.91 mm), normal depth (2.91–3.24 mm), and deep (>3.24 mm). The 
measurement of AL was divided into short (<24 mm), normal length 
(24–26 mm), and long (>26 mm). Last, the measurement of LT was 
grouped into the thin lens (<3.59 mm), normal thickness lens (3.59–
5.07), and thick lens (>5,07).
DNA isolation was extracted from patient’s blood samples and 
PCR sequencing was performed for genotyping polymorphisms 
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rs3753841 (COL11A1). PCR was performed using primers, as shown 
in Table 1.
A final volume of 25 μL of blood serum containing 100 ng DNA 
templates, 12.5 uL of GoTaq Green Master Mix Promega, and 0.4 μM 
of primers was used for PCR sequencing. PCR was performed with an 
initial denaturation at 95°C for 3 min, then followed by 35 cycles of a 
series of processes including denaturation at 95°C for 30 s, annealing 
at 63°C for 30 s, and elongation at 72°C for 1 min. The PCR sequencing 
process ended with the final elongation stage at 72°C for 5 min. PCR 
products were observed with electrophoresis using 1.5% agarose gel, 
colored with GelRed DNA then observed with GelDoc. The PCR products 
were measured at 844 bp.
The remaining PCR products were sent to Singapore’s 1st BASE 
for sequencing. Sequencing data were analyzed using Geneious 
bioinformatics software. The sequencing data for each sample from 
the forward primer were combined with the sequencing data from the 
reverse primer. Furthermore, the data were compared to BLAST on the 
NCBI website (http://blast.ncbi.nlm.nih.gov/Blast.cgi).
Polymorphism of rs3753841 (COL11A1) and biometric parameters 
were statistically analyzed between both groups. Statistical analysis 
was performed using the Statistical Package for the Social Sciences 
software version 17 (SPSS v17, IBM Corp., New York, NY, USA). 
Categorical data were compared using the Chi-square test and 
numerical data were compared using t-test. p<0.05 were considered 
as a significant difference. Mean values were reported with standard 
deviation (mean±SD).
RESULTS
This study is part of a larger study in which the correlation between 
ocular biometric parameters and gene polymorphisms previously 
found in PACG are evaluated thoroughly. Based on gender, there was 
no significant difference between the 2 groups (p=0.48). Acute PACG 
patients were younger (58.04±8.70 years) compared to chronic PACG 
patients (61.64±9.17 years), but the difference was not statistically 
significant.
We found no significant difference in ocular biometric measurements 
in both groups, as shown in Table 2 (p=0.494). Nevertheless, mean 
ACD was slightly shallower (2.40±0.40 mm) in acute PACG compared to 
chronic PACG (2.47±0.32 mm). The mean AL was shorter in acute PACG 
(21.86±1.31 mm) compared to chronic PACG group (22.71±1.54), yet 
with no significant difference (p=0.319). There was also no significant 
difference in LT measurement between the two groups (p=0.432), 
although its mean value was found to be thicker in acute PACG 
(5.01±0.49 mm) compared to chronic PACG (4.91±0.42).
We classified and statistically compared each ocular biometric 
parameter into three categories. The measurement of ACD was 
grouped into shallow (<2.91 mm), normal depth (2.91–3.24 mm), and 
deep (>3.24 mm). The values of AL was grouped into short (<24 mm), 
normal length (24–26 mm), and long (>26 mm), while LT was grouped 
into thin (<3.59 mm), normal thickness (3.59–5.07 mm), and thick lens 
(>5.07 mm). Using Chi-square test, we compared all those categories, 
as shown in Table 3.
Table 3 shows no significant differences in ocular biometric parameters 
between the 2 groups (p>0.05). Nevertheless, most of the patients in 
both groups had a shallow ACD (<2.91 mm). Furthermore, we classified 
ACD measurement more specifically into three groups; <2.10 mm, 2.10–
2.49 mm, and 2.50–2.90 mm. Based on AL measurement, all patients 
in both groups had a short AL (<24 mm). Therefore, we also classified 
short AL measurement more specifically into 3 ranges; <21 mm, 21–22 
mm, and 23–24 mm, as shown in Table 4.
We found a statistically significant difference in a more specific 
classification of shallow AL measurement between the two groups 
PACG (p=0.033), but no significant difference in the classification of 
shallow ACD measurement. Based on Table 4, in the acute PACG group, 
there were more patients with AL measurement of <21 mm, meanwhile 
AL measurements of chronic PACG patients were mostly within the 
range of 21–22 mm. These results showed that AL might have an 
important role in the mechanism of the crowded anterior segment and 
the progression of PACG into acute or chronic stage.
Polymorphisms of rs3753841 (COL11A1) in both groups consisted of 
wild type (CC), homozygous mutant (TT), and heterozygous mutant (CT). 
Electrophoresis and DNA bands from the isolated gene are shown in Fig. 1.
In this study, we found a significant difference in rs3753841 (COL11A1) 
polymorphism in which homozygous mutant was the most common 
type of mutation in acute PACG (p=0.009), meanwhile heterozygous 
mutant was the most common mutation in chronic PACG, as shown in 
Table 5.
Correlation between rs3753841 (COL11A1) polymorphisms and ocular 
biometry parameters was analyzed between the two groups. Table 6 
Table 1: Primers for genotyping rs3753841 (COL11A1)
Primers Nucleotide PCR product size
rs3753841 F 5’-GGTCCCCTCTAATGTGGCAT-3’ 844 bp
rs3753841 R 5’-GGTACCTCTCACTCTCCGCA-3’
Table 2: Mean values of biometric parameters in acute and 
chronic PACG
Biometric parameters Acute PACG Chronic PACG p‑value
ACD (mm) 2.40±0.40 2.47±0.32 0.494
AL (mm) 21.86±1.31 22.71±1.54 0.319
LT (mm) 5.01±0.49 4.91±0.42 0.432
ACD: Anterior chamber depth, AL: Axial length, LT: Lens thickness, 
PACG: Primary angle-closure glaucoma
Table 3: Comparison of ocular biometric parameters in acute 
and chronic PACG
Biometric parameters Acute PACG Chronic PACG p‑value
ACD (mm)








<3.59 0 0 0.915
3.59–5.07 14 16
>5.07 11 9
ACD: Anterior chamber depth, AL: Axial length, LT: Lens thickness, 
PACG: Primary angle-closure glaucoma
Table 4: Comparison of ranges in shallow ACD and short AL
Biometric parameters Acute PACG Chronic PACG p‑value
ACD (mm)




<21 21 3 0.033
21–22 4 18
23–24 0 4
ACD: Anterior chamber depth, AL: Axial length, PACG: Primary angle-closure 
glaucoma
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shows the correlation between polymorphisms and ocular biometry 
in the acute PACG group. Based on Table 6, there was no significant 
correlation between rs3753841 (COL11A1) polymorphism and ocular 
biometry parameters (p>0.05) in acute PACG. In this group, the 
homozygous mutant polymorphism was most frequent in shallow ACD, 
short AL, and thick lens.
In the chronic PACG group, we found a statistically significant 
correlation between genetic polymorphisms and ocular biometry, as 
shown in Table 7. This significant correlation of genetic mutation was 
found especially with ACD (p=0.009) and AL (p=0.01), but there was 
no correlation with LT (p=0.59). There was a tendency of different 
mutations between the two groups. While homozygous mutant was 
more common in acute PACG, heterozygous mutant was found to be 
more related with shallow ACD and short AL in chronic PACG.
DISCUSSION
There are several terminologies and classifications related to angle-
closure glaucoma. In general, angle-closure glaucoma is divided into 
primary angle-closure suspect (PACS), primary angle-closure (PAC), 
and PACG. This classification is based on intraocular pressure (IOP), 
gonioscopy examination, optic nerve evaluation, and visual field defect. 
PACS is defined as the non-visibility of the trabecular meshwork for 
180 degrees or more. In PACS, contact between peripheral iris and 
peripheral trabecular meshwork is present but not accompanied by 
PAS and increased IOP [7-9].
PAC indicated by shallow anterior chamber angle (ACA) and signs of 
trabecular meshwork obstruction by peripheral iris and absence of 
glaucomatous optic neuropathy during fundus examination. PACG, 
on the other hand, is indicated by conditions of PAC but followed by 
glaucomatous optic neuropathy finding. Clinical manifestation of PACG 
based on duration and onset is divided into acute PACG (20–30% of 
cases) and chronic PACG (70–80% of cases) [7,8,10].
Acute PACG transpires when the entire trabecular meshwork is covered 
expeditiously by peripheral iris, causing a sudden increase in IOP and 
if not lowered immediately, this condition will cause damage to the 
intraocular structure, especially the optic nerve, which later can result 
in visual impairment. Otherwise, chronic PACG is indicated by the 
gradual movement of peripheral iris to cover trabecular meshwork and 
form of peripheral anterior synechiae (PAS). These synechiae can occur 
in certain effects only in a small quadrant at an early stage, but then it 
can gradually expand on the whole surface of the trabecular meshwork. 
This condition is usually asymptomatic because IOP gradually increases 
over a long period of time so that the eye has enough time to adjust to 
high IOP and finally all the axons in the optic nerve are damaged and a 
visual field defect arises [7,8,10].
In this study, we found the polymorphisms of rs3753841 (COL11A1) 
polymorphisms in both PACG groups. Nevertheless, there were 
different trends between the two groups; homozygous mutant was the 
most common type of mutation in acute PACG group while in chronic 
PACG group, heterozygous mutant was the most common type and this 
difference was statistically significant.
The COL11A1 gene is known to play a role in the production of Type 
XI collagen components, known as pro-alpha1 (XI) chains, which is 
one of the main components of the extracellular matrix. Extracellular 
matrix is one of the components of tissues involved in the path of the 
aqueous humor flow; therefore, the variation of this gene is thought 
to play a role in causing resistance to the flow of the aqueous humor 
and IOP elevation. In addition, an incremented regulation of COL11A1 
gene mutation was found in glaucoma patients, which indicates the 
involvement and expression of extracellular matrix genes in the 
pathogenesis of glaucoma. The COL11A1 gene mutation was known to 









Wild type (CC) (1) 4 (3) 12 (4) 8 0.009
Mutant homozygote (TT) (14) 56 (8) 32 (22) 44
Mutant heterozygote (CT) (10) 40 (14) 56 (24) 48
PACG: Primary angle-closure glaucoma
Table 6: Correlation between polymorphisms and ocular biometry in acute PACG
Polymorphism locus rs3753841 ACD p‑value AL p‑value LT p‑value
<2.91 2.91–3.24 >3.24 <24 3.59–5.07 >5.07
Wild type (CC) 1 0 0 0.39 1 0.11 1 0 0.39
Mutant homozygote (TT) 11 1 2 14 8 6
Mutant heterozygote (CT) 10 0 0 10 8 2
Total 22 1 2 25 17 8
ACD: Anterior chamber depth, AL: Axial length, LT: Lens thickness, PACG: Primary angle-closure glaucoma
Table 7: Correlation between polymorphisms and ocular biometry in chronic PACG
Polymorphism locus rs3753841 ACD p‑value AL p‑value LT p‑value
<2.91 2.91–3.24 >3.24 <24 3.59–5.07 >5.07
Wild type (CC) 3 0 0 0.01 3 0.00 3 0 0.59
Mutant homozygote (TT) 6 2 0 8 6 0
Mutant heterozygote (CT) 14 0 0 14 14 2
Total 23 2 0 25 23 2
ACD: Anterior chamber depth, AL: Axial length, LT: Lens thickness, PACG: Primary angle-closure glaucoma
Fig. 1: Electrophoresis and DNA extraction results showing DNA 
bands from the isolated gene
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play a role in Marshall syndrome and Type 2 Stickler syndrome, both of 
which have non-progressive axial myopia features [4,7,11].
The COL11A1 gene additionally has the role of regulating the production 
of type XI collagen components, known as pro-alpha1 (XI) chains. This 
Type XI collagen can be found in tissues, such as the inner ear, vitreous, 
and pulposus nucleus, which is the middle part of the disk between the 
spines. Type XI collagen additionally avails maintaining distance and 
width of collagen Type II molecules which is an important component 
of vitreous and cartilage [4,7].
This study is the first study of gene polymorphisms in PACG subtype 
conducted in Southeast Asia. It is thought that there might be a 
possibility of ethnic factors having an important in polymorphisms 
of rs3753841 (COL11A1) in PACG. Based on ethnicity, a statistically 
significant correlation between COL11A1 polymorphisms and PACG 
was found in Australia (p=0.017) [5]. However, other studies in Nepal 
(p=0.308), China (p=0.054), and South India (p=0.127) showed 
no significant relationship between these genetic polymorphisms 
and glaucoma [5,6,12]. Therefore, we can conclude that based on 
ethnicity, our study is the second study after the Australian population, 
which resulted a significant correlation between COL11A1 and PACG, 
especially in chronic subtypes.
Previous ocular biometric studies have shown that eyes with PACG 
have several distinct characteristics compared to normal eyes, such as 
a shallower anterior chamber, thicker lens, and shorter AL [3,13]. Eyes 
with PACG usually have anatomical features of the small cornea, shallow 
ACD, thick lens, anteriorly positioned lens, and short AL. Furthermore, 
some cases of angle-closure glaucoma are not fully explained by 
these anatomical risk factors. With the increasing use of new anterior 
chamber assessment techniques such as ultrasound bio-microscopy 
and optical coherence tomography, anterior segment parameters can 
be precisely measured [14-16]. To the best of our knowledge, variation 
in ocular biometric measurements between acute and chronic PACG has 
not been widely evaluated.
In this study, we classified PACG based on its clinical presentation, 
particularly the suddenness of the attacks, into acute and chronic 
PACG. Acute PACG is identified by rapid movement of iris covering the 
entire trabecular meshwork, causing a sudden and rapid symptomatic 
elevation of IOP. If this condition does not resolve spontaneously or 
immediately under medical intervention, it will get worse into an 
advanced chronic stage. Otherwise, in chronic PACG, the iris gradually 
covers the trabecular meshwork, leading to the formation of PAS.
The PAS is usually distinct or multi-centered at first, then gradually 
expand and fuse together, covering the trabecular meshwork in its 
entirety.[7,8] Chronic PACG is often painless and asymptomatic because 
of gradual elevation of IOP in a long period of time; thus the eyes have 
the time to adapt to those changes in IOP. This classification can be used 
in determining the appropriate medical intervention for PACG based on 
its clinical presentation [7].
In this study, the ACD measurement was grouped into shallow (<2.91 mm), 
normal (2.91–3.24 mm), and deep (>3.24 mm). AL value was classified 
into short (<24 mm), normal (24–26 mm), and long (> 26 mm), while 
LT measurement was divided into thin (<3.59 mm), normal (3.59–
5.07), and thick (>5.07). There was a tendency for ACD to be deeper 
and for LT to be thicker than the normal values. Meanwhile, based 
on AL classification, all patients in both groups were in the short AL 
category. Nevertheless, there was no statistically significant difference 
in ocular biometry measurement between the two groups. Therefore, 
it is estimated that other trigger factors, such as poor lighting, might 
contribute to the development of acute or chronic PACG instead of its 
high-risk anatomical features of the anterior segment.
ACD is determined by various factors such as gender and race or 
ethnicity. The deepest ACD is within the central area which is normally 
around 3 mm. Feng et al. conducted ACD evaluation in several countries 
representing all continents and estimated that the average ACD of the 
central area was 3.11 mm, with a normal range of 2.91–3.24 mm [19]. 
When compared to that normal value, the mean ACD measurement in 
this study was below the normal range. Previously, Razeghinejad and 
Banifatemi evaluated ocular biometry in angle-closure and obtained an 
average ACD in acute PACG of 2.52±0.22 mm [3].
The mean AL measurement obtained in this study was 21.86±1.31 mm 
for acute PACG and 21.86±1.31 mm for chronic PACG. Previous studies 
found that PACG patients had shorter AL than normal value. Thapa et al. 
compared average AL of occludable angle with the normal population 
and found mean AL of 22.8±0.83 mm in subjects with occludable 
angle, which was significant when compared to the normal population 
(p<0.05) [15]. That result was slightly different from the average AL 
measurement obtained in our study.
Since all patients in both groups had short AL category, we then 
classified the short AL into more specific ranges; <21 mm, 21–22 mm, 
and 23–24 mm. Based on that classification, we found a significant 
difference in both groups, in which acute PACG patients had shorter AL 
compared to chronic PACG patients. This result showed the possibilities 
of AL measurement having a more significant value in causing a 
crowded anterior segment, in line with the progression of PAC/PACG 
into the acute or chronic stage.
Razeghinejhad and Banifatemi found no significant difference in the 
average value of AL among PACS, PACG, and APAC (p=0.287), with 
the shortest AL were found in the APAC group. Similar to that study, 
even though we found no statistically significant difference in AL 
measurement between the two groups (p>0.05), yet we can conclude 
that both acute and chronic PACG patients had shorter AL compared to 
normal value. Furthermore, we found that the average AL measurement 
in acute PACG was shorter compared to those of chronic PACG. This 
result might suggest that eyes with shorter AL might have a higher risk 
of developing of PACG into the acute attack.
The lens is generally thicker in PACG than in normal eyes. This thicker 
lens is usually followed by a more anteriorly-positioned lens. Lowe 
estimated that thick crystalline lenses caused narrowing of the ACD 
up to 0.35 mm, but more anteriorly-positioned lens could narrow 
down the ACD up to 0.65 mm. The increase in LT value is also in line 
with age because of the lens growth with an increased number of lens 
fibers occurring continuously for a lifetime [13,20]. Razeghinejad and 
Banifatemi found that the mean LT in PACG was 4.54±0.47 mm [3]. 
The mean LT value in our study was not much different from previous 
studies. We obtained a mean LT of 5.01±0.49 mm in acute PACG and 
4.91±0.42 mm in chronic PACG.
The correlation between polymorphisms of rs3753841 (COL11A1) 
and ocular biometry was also evaluated in both groups. In this study, 
a significant correlation was obtained between rs3753841 (COL11A1) 
polymorphisms and ocular biometry in chronic PACG. This genetic 
polymorphism was especially correlated with ACD (p=0.009) and AL 
(p=0.01), but no significant relationship was found with LT (p=0.599). 
Previous  ocular  biometry  studies  have  indicated  that  eyes  with 
PACG usually present with different characteristics compared to 
those  of  normal  eyes,  such  as  shallow  ACD,  thicker  LT,  and 
shorter  AL.  When  compared  within  angle-closure  classification,  the 
study  by  George  et  al.  showed  that  there  were  no  significant 
differences  in  ocular  biometric  parameters  between  patients  with 
occludable angle and angle-closure glaucoma [3]. Low compared
 ocular  biometry  values  in  normal  population  versus  eyes 
with  PACG  and  indicated  that  shallow  ACD  in  eyes  with  PACG  was 
possibly caused by incoordination between the lens and AL.  A thick lens 
with  a  more  posterior  position  can  cause  rotation  of  the  corpus  ciliary, 
which can narrow down the ACA [15,17]. An eye with ACD of 2.5 mm or 
more was found to be less likely to develop into PACG. Another study in 
Nepal also found that AL was shorter in eyes with PACG than in 
the  normal  group  [15,18].  Therefore,  initial  assessment  of  ocular 
biometric  parameters  can  be  used  as  a  screening  tool  for 
patients with angle-closure glaucoma.
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Heterozygous mutants were the most common mutations related to 
shallow ACD and short AL. In contrast to chronic PACG, the correlation 
between rs3753841 (COL11A1) polymorphisms with ocular biometry 
in acute PACG was not statistically significant (p>0.05).
Correlation between molecular genetics with ocular biometry 
parameters in angle-closure glaucoma has not been largely evaluated. 
One of the few studies that evaluated the correlation between ocular 
biometry and these genetic polymorphisms was the study by Shi 
et al., who found no significant correlation with ocular biometry in 
the PAC group, although these polymorphisms were detected in eyes 
with PACG [21]. Our results also supported a recent study by Wan 
et al. in China, which confirmed the role of COL11A1 polymorphisms 
as a potential gene for developing PACG and the possibility of these 
polymorphisms to be related to the course of PACG [11].
CONCLUSION
Based on our results, we confirmed the role of rs3753841 (COL11A1) 
polymorphisms in chronic PACG and its correlation with shallow ACD 
and short AL. Therefore, this study also showed that one of the possible 
mechanisms of slow course in angle-closure of chronic PACG might be 
affected by the genetic mutations. In addition, no significant correlation 
found between the rs3753841 (COL11A1) polymorphisms and ocular 
biometry in acute PACG can indicate the role of other factors, other than 
anatomical features, that are more dominantly affecting the course of 
the disease into an acute onset or sudden pupillary block leading to a 
sudden increase in IOP.
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